Literature DB >> 15640397

Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression.

Qing-Li Wu1, Yun-Feng Fu, Wen-Liang Zhou, Jun-Xia Wang, Yong-Hong Feng, Jing Liu, Jian-Yi Xu, Pei-Lan He, Ru Zhou, Wei Tang, Gui-Feng Wang, Yu Zhou, Yi-Fu Yang, Jian Ding, Xiao-Yu Li, Xiao-Ru Chen, Chong Yuan, Brian R Lawson, Jian-Ping Zuo.   

Abstract

Lymphocytes depend on transmethylation reactions for efficient activation and function. These reactions are primarily catalyzed by S-adenosylmethionine-dependent methyltransferases, which convert S-adenosylmethionine to S-adenosyl-L-homocysteine. S-adenosyl-L-homocysteine is then hydrolyzed by S-adenosyl-L-homocysteine hydrolase to prevent feedback inhibition of transmethylation reactions. By impeding S-adenosyl-L-homocysteine hydrolase, a build-up of S-adenosyl-L-homocysteine occurs, and most intracellular transmethylation reactions cease. Thus, a nontoxic inhibitor of this enzyme might be a useful immunosuppressive therapeutic agent. We identified a potent reversible type III inhibitor of S-adenosyl-L-homocysteine hydrolase, DZ2002 [methyl 4-(adenin-9-yl)-2-hydroxybutanoate], and determined its cytotoxic and immunologic effects. We demonstrated that DZ2002 blocked S-adenosyl-L-homocysteine hydrolase more effectively than a type I inhibitor, but cytotoxicity from DZ2002 was greatly reduced. Although DZ2002 did not prevent concanavalin A-induced T cell proliferation or interleukin (IL)-2 production, it significantly reduced both a mixed lymphocyte reaction and IL-12 production from in vitro-stimulated splenocytes. In addition, levels of CD80 and CD86 on human monocytic THP-1 cells were decreased in a dose-dependent manner in the presence of 0.1 to 10 microM DZ2002, and decreases were also seen in IL-12 and tumor necrosis factor-alpha production from both mouse thioglycollate-stimulated peritoneal macrophages and THP-1 cells. In vivo, DZ2002 significantly suppressed a delayed-type hypersensitivity reaction as well as antibody secretion. We conclude that DZ2002's immunosuppressive effects are likely not solely attributed to T cell inhibition but also to the obstruction of macrophage activation and function through reductions in cytokine output and/or T cell costimulation. These data suggest an important dual role for the S-adenosyl-l-homocysteine hydrolase in both macrophage and T cell function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640397     DOI: 10.1124/jpet.104.080416

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling.

Authors:  Douglas J Kominsky; Simon Keely; Christopher F MacManus; Louise E Glover; Melanie Scully; Colm B Collins; Brittelle E Bowers; Eric L Campbell; Sean P Colgan
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

2.  Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17+ RORγt+ /IL-10+ FoxP3+ ratio.

Authors:  Y Su; Q Wang; B Yang; L Wu; G Cheng; H Kuang
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

Review 3.  Transmethylation in immunity and autoimmunity.

Authors:  Brian R Lawson; Theodoros Eleftheriadis; Virginie Tardif; Rosana Gonzalez-Quintial; Roberto Baccala; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2011-12-24       Impact factor: 3.969

Review 4.  Metabolic shifts in immunity and inflammation.

Authors:  Douglas J Kominsky; Eric L Campbell; Sean P Colgan
Journal:  J Immunol       Date:  2010-04-15       Impact factor: 5.422

5.  Role of glycine N-methyltransferase in the regulation of T-cell responses in experimental autoimmune encephalomyelitis.

Authors:  Chung-Hsien Li; Ming-Hong Lin; Shih-Han Chu; Pang-Hsien Tu; Cheng-Chieh Fang; Chia-Hung Yen; Peir-In Liang; Jason C Huang; Yu-Chia Su; Huey-Kang Sytwu; Yi-Ming Arthur Chen
Journal:  Mol Med       Date:  2015-03-24       Impact factor: 6.354

6.  Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.

Authors:  J-X Wang; W Tang; L-P Shi; J Wan; R Zhou; J Ni; Y-F Fu; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2007-01-29       Impact factor: 8.739

7.  Lupus autoimmunity altered by cellular methylation metabolism.

Authors:  Mei-Ling Yang; Alaric J P Gee; Renelle J Gee; Cecilia I Zurita-Lopez; Shilpi Khare; Steven G Clarke; Mark J Mamula
Journal:  Autoimmunity       Date:  2012-11-01       Impact factor: 2.815

8.  Effect of hexane fraction of leaves of Cinnamomum tamala Linn on macrophage functions.

Authors:  J K Chaurasia; Nidhi Pandey; Yamini Bhushan Tripathi
Journal:  Inflammopharmacology       Date:  2010-01-14       Impact factor: 4.473

9.  Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.

Authors:  Shi-jun He; Ze-min Lin; Yan-wei Wu; Bing-xin Bai; Xiao-qian Yang; Pei-lan He; Feng-hua Zhu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2013-12-30       Impact factor: 6.150

10.  LPS-induced genes in intestinal tissue of the sea cucumber Holothuria glaberrima.

Authors:  Francisco Ramírez-Gómez; Pablo A Ortiz-Pineda; Gabriela Rivera-Cardona; José E García-Arrarás
Journal:  PLoS One       Date:  2009-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.